100 related articles for article (PubMed ID: 28070500)
1. Chimeric influenza haemagglutinins: Generation and use in pseudotype neutralization assays.
Ferrara F; Temperton N
MethodsX; 2017; 4():11-24. PubMed ID: 28070500
[TBL] [Abstract][Full Text] [Related]
2. Pseudotype Neutralization Assays: From Laboratory Bench to Data Analysis.
Ferrara F; Temperton N
Methods Protoc; 2018 Jan; 1(1):. PubMed ID: 31164554
[TBL] [Abstract][Full Text] [Related]
3. The human Transmembrane Protease Serine 2 is necessary for the production of Group 2 influenza A virus pseudotypes.
Ferrara F; Molesti E; Böttcher-Friebertshäuser E; Cattoli G; Corti D; Scott SD; Temperton NJ
J Mol Genet Med; 2012; 7():309-14. PubMed ID: 23577043
[TBL] [Abstract][Full Text] [Related]
4. Pseudotype-based neutralization assays for influenza: a systematic analysis.
Carnell GW; Ferrara F; Grehan K; Thompson CP; Temperton NJ
Front Immunol; 2015; 6():161. PubMed ID: 25972865
[TBL] [Abstract][Full Text] [Related]
5. Characterization of lentiviral pseudotypes with influenza H5N1 hemagglutinin and their performance in neutralization assays.
Wang W; Xie H; Ye Z; Vassell R; Weiss CD
J Virol Methods; 2010 May; 165(2):305-10. PubMed ID: 20153374
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
[TBL] [Abstract][Full Text] [Related]
7. The use of equine influenza pseudotypes for serological screening.
Scott S; Molesti E; Temperton N; Ferrara F; Böttcher-Friebertshäuser E; Daly J
J Mol Genet Med; 2012; 6():304-8. PubMed ID: 23515229
[TBL] [Abstract][Full Text] [Related]
8. Exploiting Pan Influenza A and Pan Influenza B Pseudotype Libraries for Efficient Vaccine Antigen Selection.
Del Rosario JMM; da Costa KAS; Asbach B; Ferrara F; Ferrari M; Wells DA; Mann GS; Ameh VO; Sabeta CT; Banyard AC; Kinsley R; Scott SD; Wagner R; Heeney JL; Carnell GW; Temperton NJ
Vaccines (Basel); 2021 Jul; 9(7):. PubMed ID: 34358157
[TBL] [Abstract][Full Text] [Related]
9. The Use of Hyperimmune Chicken Reference Sera Is Not Appropriate for the Validation of Influenza Pseudotype Neutralization Assays.
Ferrara F; Molesti E; Scott S; Cattoli G; Temperton N
Pathogens; 2017 Sep; 6(4):. PubMed ID: 28946689
[TBL] [Abstract][Full Text] [Related]
10. A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice.
Nachbagauer R; Kinzler D; Choi A; Hirsh A; Beaulieu E; Lecrenier N; Innis BL; Palese P; Mallett CP; Krammer F
NPJ Vaccines; 2016; 1():16015-. PubMed ID: 29250436
[TBL] [Abstract][Full Text] [Related]
11. An optimised method for the production of MERS-CoV spike expressing viral pseudotypes.
Grehan K; Ferrara F; Temperton N
MethodsX; 2015; 2():379-84. PubMed ID: 26587388
[TBL] [Abstract][Full Text] [Related]
12. Sequential Infection in Ferrets with Antigenically Distinct Seasonal H1N1 Influenza Viruses Boosts Hemagglutinin Stalk-Specific Antibodies.
Kirchenbaum GA; Carter DM; Ross TM
J Virol; 2016 Jan; 90(2):1116-28. PubMed ID: 26559834
[TBL] [Abstract][Full Text] [Related]
13. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
[TBL] [Abstract][Full Text] [Related]
14. Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen.
Pleckaityte M; Bremer CM; Gedvilaite A; Kucinskaite-Kodze I; Glebe D; Zvirbliene A
BMC Biotechnol; 2015 Sep; 15():85. PubMed ID: 26370129
[TBL] [Abstract][Full Text] [Related]
15. Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge.
Isakova-Sivak I; Matyushenko V; Kotomina T; Kiseleva I; Krutikova E; Donina S; Rekstin A; Larionova N; Mezhenskaya D; Sivak K; Muzhikyan A; Katelnikova A; Rudenko L
Vaccines (Basel); 2019 Jul; 7(3):. PubMed ID: 31288422
[TBL] [Abstract][Full Text] [Related]
16. Influenza A haemagglutinin specific IgG responses in children and adults after seasonal trivalent live attenuated influenza vaccination.
Islam S; Mohn KG; Krammer F; Sanne M; Bredholt G; Jul-Larsen Å; Tete SM; Zhou F; Brokstad KA; Cox RJ
Vaccine; 2017 Oct; 35(42):5666-5673. PubMed ID: 28899626
[TBL] [Abstract][Full Text] [Related]
17. Chimeric Hemagglutinin-Based Influenza Virus Vaccines Induce Protective Stalk-Specific Humoral Immunity and Cellular Responses in Mice.
Choi A; Bouzya B; Cortés Franco KD; Stadlbauer D; Rajabhathor A; Rouxel RN; Mainil R; Van der Wielen M; Palese P; García-Sastre A; Innis BL; Krammer F; Schotsaert M; Mallett CP; Nachbagauer R
Immunohorizons; 2019 Apr; 3(4):133-148. PubMed ID: 31032479
[TBL] [Abstract][Full Text] [Related]
18. Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model.
Liu WC; Nachbagauer R; Stadlbauer D; Solórzano A; Berlanda-Scorza F; García-Sastre A; Palese P; Krammer F; Albrecht RA
Front Immunol; 2019; 10():756. PubMed ID: 31105689
[TBL] [Abstract][Full Text] [Related]
19. Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin.
Isakova-Sivak I; Korenkov D; Smolonogina T; Kotomina T; Donina S; Matyushenko V; Mezhenskaya D; Krammer F; Rudenko L
Virology; 2018 May; 518():313-323. PubMed ID: 29574336
[TBL] [Abstract][Full Text] [Related]
20. Complement-mediated enhancement of antibody function for neutralization of pseudotype virus containing hepatitis C virus E2 chimeric glycoprotein.
Meyer K; Basu A; Przysiecki CT; Lagging LM; Di Bisceglie AM; Conley AJ; Ray R
J Virol; 2002 Mar; 76(5):2150-8. PubMed ID: 11836392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
